共 23 条
[1]
Upregulation of the vascular NAD(P)H-oxidase isoforms NOX1 and NOX4 by the renin-angiotensin system in vitro and in vivo. Kirstin W,Sandra W,Reinhold K,Lars R,Martin P,Harald HH. Free Radical Biology and Medicine . 2001
[2]
Impaired superoxide production due to a deficiency in phagocyte NADPH oxidase fails to inhibit atherosclerosis in mice. Kirk EA,Dinauer MC,Rosen H,Chait A,Heinecke JW,LeBoeuf RC. Arteriosclerosis and Thrombosis . 2000
[3]
Upregulation of NOX-based NAD (P)H oxidase in restenosis after carotid injury. Katalin S,Bernard L,Dan S,Lula LH,Liisa V,Tracey LC,et al. Arteriosclerosis and Thrombosis . 2002
[4]
Mechanistic role of cytochrome P450 monooxygenases in oxidized low-density lipoprotein-induced vascular injury: therapy through LOX-1 receptor antagonism. Thum T,Borlak J. Circulation Research . 2004
[5]
Intracelluar Localization and pre-assembly of the NADPH oxidase complex in cultured endothelial cells. Li J-M,Shah AM. Journal of Biological Chemistry . 2002
[6]
Azelnidipine, A newly developed long-acting calcium antagonist, inhibits tumor necrosis factor-alpha-induced interleukin-8 expression in endothelial cells through its anti-oxidative properties. Yamagishi S,Inagaki Y,Nakamura K,Imaizumi Y. Journal of Cardiovascular Pharmacology . 2004
[7]
Vascular effects following homozygous disruption of P47phox an essential component of NADPH oxidase. Eileen H,Brahm HS,Patrick JP,Federico ER,Beverly P,John D,et al. Circulation . 2000
[8]
p47phox is required for atherosclerotic lesion progression in ApoE-/-mice. Patricia AB,Cam P,Marie M,Zhaoyong H,Stephen MH,Edward HY,et al. The Journal of Clinical Investigation . 2001
[9]
Increased myocardial NADPH oxidase activity in human heart failure. Christophe H,Jennifer KB,Philippe R,Alison CC,Jane LS,Gerd H,et al. Journal of the American College of Cardiology . 2003
[10]
Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Jian-Mei L,Nick PG,David JG,Mingyou C,Ajay MS. Journal of Hypertension . 2002